XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Treasury Stock
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle (Note 2) $ 1,530,291 $ 1,913 $ 4,126,549 $ (56,440) $ (2,541,294) $ 0 $ (437)
Balances at beginning of period at Dec. 31, 2017 1,530,291 1,913 4,126,549 (56,440) (2,541,294) 0 (437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   1 1,468        
Issuance of warrants     0        
Restricted stock, net   26 (26)        
Shares withheld for employee taxes   (4) (3,057)        
Other, net   32 146   280    
Compensation expense related to restricted stock grants     26,067        
Purchase of treasury stock (8,500)     (8,500)      
Cumulative effect of change in accounting principle (Note 2) 1,018,413 1,913 4,126,549 (64,940) (3,069,272) 0 (437)
Net income (loss) (528,352)       (528,258)   (94)
Noncontrolling interest contribution             41
Noncontrolling interest distribution             0
Balances at end of period at Dec. 31, 2018 $ 1,018,413 $ 1,968 4,151,147 (64,940) (3,069,272) (55,885) (490)
Balances at beginning of period (in shares) at Dec. 31, 2017   191,276,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   207,000          
Restricted stock, net (in shares)   2,593,000          
Shares withheld for employee taxes (in shares)   (439,000)          
Purchase of treasury stock (in shares) (1,281,000) (1,281,000)          
Balances at end of period (in shares) at Dec. 31, 2018   192,356,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle (Note 2) $ 1,018,413 $ 1,968 4,151,147 (64,940) (3,069,272) (55,885) (490)
Issuance of common stock under Associate Stock Purchase Plan   2 1,160        
Issuance of warrants     0        
Restricted stock, net   31 (31)        
Shares withheld for employee taxes   (5) (3,308)        
Other, net   0 105   0    
Compensation expense related to restricted stock grants     23,026        
Purchase of treasury stock (19,710)     (19,711)      
Cumulative effect of change in accounting principle (Note 2) 1,018,413 1,968 4,151,147 (64,940) (3,069,272) (55,885) (490)
Net income (loss) (268,492)       (267,931)   (561)
Noncontrolling interest contribution             6,566
Noncontrolling interest distribution             (3,146)
Balances at end of period at Dec. 31, 2019 $ 698,725 $ 1,996 4,172,099 (84,651) (3,393,088) (115) 2,369
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   181,000          
Restricted stock, net (in shares)   3,073,000          
Shares withheld for employee taxes (in shares)   (476,000)          
Purchase of treasury stock (in shares) (3,005,000) (3,005,000)          
Balances at end of period (in shares) at Dec. 31, 2019 192,128,586 192,129,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle (Note 2) $ 698,725 $ 1,996 4,172,099 (84,651) (3,393,088) (115) 2,369
Issuance of common stock under Associate Stock Purchase Plan   2 638        
Issuance of warrants     22,883        
Restricted stock, net   (9) 9        
Shares withheld for employee taxes   (6) (4,037)        
Other, net   0 70   0    
Compensation expense related to restricted stock grants     20,747        
Purchase of treasury stock (18,123)     (18,123)      
Cumulative effect of change in accounting principle (Note 2) 698,725 1,983 4,212,409 (84,651) (3,311,184) $ (115) 2,295
Net income (loss) 81,945       82,019   (74)
Noncontrolling interest contribution             0
Noncontrolling interest distribution             0
Balances at end of period at Dec. 31, 2020 $ 802,729 $ 1,983 4,212,409 (102,774) (3,311,184)   2,295
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   224,000          
Restricted stock, net (in shares)   (830,000)          
Shares withheld for employee taxes (in shares)   (656,000)          
Purchase of treasury stock (in shares) (3,063,000) (3,063,000)          
Balances at end of period (in shares) at Dec. 31, 2020 187,804,138 187,804,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle (Note 2) $ 802,729 $ 1,983 $ 4,212,409 $ (102,774) $ (3,311,184)   $ 2,295